Document Detail


Identification and management of delirium in the critically ill patient with cancer.
MedLine Citation:
PMID:  12574707     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rather than a specific entity, delirium is at the midpoint on a spectrum of potential mental status changes that ranges from full consciousness to deep coma. The extremes are relatively easy to recognize, but other points along the spectrum may go unrecognized or be misdiagnosed. If recognized and treated expeditiously, delirium may be reversed in some patients. It is imperative that those caring for critically ill patients with cancer have the knowledge and tools necessary to identify and manage delirium appropriately. Although all critically ill patients are at risk for delirium, cancer presents additional assaults to the central nervous system via direct tumor invasion or iatrogenic provocations. This article describes delirium in cancer, and addresses diagnostic and management issues across the course of the disease.
Authors:
Candis Morrison
Related Documents :
23541317 - Antimüllerian hormone, the assessment of the ovarian reserve and the reproductive outc...
23350937 - Many young men with prostate-specific antigen (psa) screen-detected prostate cancers ma...
24223407 - Evaluation of primary androgen deprivation therapy in prostate cancer patients using th...
24969867 - Helicobacter pylori and pancreatic cancer risk: a meta- analysis based on 2,049 cases a...
22082307 - Nanoparticle mediated targeting of vegfr and cancer stem cells for cancer therapy.
25485267 - Endoscopic ultrasound in the diagnosis and staging of lung cancer.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  AACN clinical issues     Volume:  14     ISSN:  1079-0713     ISO Abbreviation:  AACN Clin Issues     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-07     Completed Date:  2003-04-16     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9508191     Medline TA:  AACN Clin Issues     Country:  United States    
Other Details:
Languages:  eng     Pagination:  92-111     Citation Subset:  N    
Affiliation:
Johns Hopkins University School of Nursing, Baltimore, MD 21205, USA. cmorris@son.jhmi.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Anxiety Agents / therapeutic use
Antipsychotic Agents / therapeutic use
Benzodiazepines
Delirium / diagnosis*,  etiology,  therapy*
Diagnosis, Differential
Humans
Mental Disorders / diagnosis
Neoplasms / complications*,  drug therapy,  physiopathology
Risk Factors
Terminology as Topic
Chemical
Reg. No./Substance:
0/Anti-Anxiety Agents; 0/Antipsychotic Agents; 12794-10-4/Benzodiazepines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of a treatment interference protocol on clinical decision making for restraint use in the int...
Next Document:  The male menopause: possible causes, symptoms and treatment.